☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Exscientia
Exscientia Signs AI Drug Discovery Collaboration with Merck KGaA to Discover Novel Small Molecule Drug Candidates
September 20, 2023
Exscientia Entered into a Research Collaboration with Sanofi to Develop Cancer & Immunology Therapies
January 7, 2022
BMS Exercises its Option to Develop Exscientia's AI-Designed Drug Candidate
August 18, 2021
PharmaShots Weekly Snapshots (April 05 - 09, 2021)
April 9, 2021
Load more...
Back to Home